Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Share News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: ARM Hit By iPhone Production Cut Report

Wed, 06th Jan 2016 10:18

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.
----------
FTSE 100 - WINNERS
----------
Royal Mail, up 1.9%. Barclays upgraded the postal service operator to Overweight from Equal Weight and hiked its price target to 575 pence from 440p. Royal Mail shares were trading at 444.80p. The bank expects a new pay deal to be negotiated in the first quarter of 2016 and for the company to resolve the issues around its defined benefit pension scheme by the second half. Barclays also said it was confident the cost-cutting measures Royal Mail is taking will keep costs broadly flat, allowing any rise in revenue to feed through to the bottom line. It is the second vote of confidence in Royal Mail shares in as many days. Cantor Fitzgerald upgraded the postal operator to Buy from Hold on Tuesday.

BAE Systems, up 1.9%. RBC Capital Markets upgraded its rating on BAE Systems to Top Pick from Outperform, hiking its target price to 630 pence from 570p. BAE was trading at 501p.
----------
FTSE 100 - LOSERS
----------
ARM Holdings, down 3.0%. The company, which designs semiconductors that are used in Apple's iPhones, was hit after a report in Japan's Nikkei Asian Review said Apple is expected to reduce the output of iPhone 6s and 6s Plus models by around 30% in the January-March quarter compared with its original plans. The report said inventories of the two models, which launched last September, have piled up at retailers in markets ranging from China and Japan to Europe and the US amid lackluster sales. Customers saw little improvement in performance over the previous generation, while dollar appreciation led to sharp price hikes in emerging markets.
----------
FTSE 250 - WINNERS
----------
Card Factory, up 0.9%. Card Factory has appointed Karen Hubbard as its chief executive designate, with effect from February 22. The greeting cards and gifts retailer hired Hubbard from discount retailer B&M European Value Retail, where she has been chief operating officer since 2014. Prior to this, she worked in a number of roles at Asda, the Wal-Mart Stores-owned UK supermarket chain, including heading its property, format development and multi-channel business. She will take over from Card Factory's current chief executive, Richard Hayes, in mid-April. The company also said Christmas trading had been in line with its expectations.
----------
FTSE 250 - LOSERS
----------
Home Retail Group, down 4.5%. The owner of Argos and Homebase gave back some gains made on Tuesday, when it closed up 34% following the news FTSE 100-listed grocer J Sainsbury had made an unsolicited bid for the company in November, which Home Retail rejected. Home Retail has been the subject of speculation about a potential takeover offer ever since its shares slumped in October following a profit warning, hit by investments in restructuring the business and slower-than-expected trading. Sainsbury's shares were down 0.9%.
----------
MAIN MARKET AND AIM - WINNERS
----------
Sula Iron & Gold, up 22%. The miner said its chief executive said the assay results from the recent drilling campaign on the Ferensola gold project in Sierra Leone exceeded his expectations and leads him to believe there is a major high-grade deposit. "I am excited by the results of the second batch of drill core samples from the extended scout drilling programme at our Ferensola Gold Project, together with the samples of 'goldstones' as they exceed my best-case expectations," said Nick Warrel.

Corero Network Security, up 15%. The security systems developer said it has secured a USD700,000 order for its SmartWall Threat Defense System product from an undisclosed European internet service provider. Under the order Corero will provide protection against distributed denial of service attacks, a form of hack that makes on online service unavailable by overwhelming it with traffic from multiple sources, as a service for one of the ISP's "high profile" customers.

Midatech Pharma, up 12%. The specialty pharmaceutical company said 2015 revenue will be "slightly ahead of expectations" following its recent acquisitions of Dara BioSciences and Zuplenz, and it also forecast revenue growth at the higher end of market forecasts for 2016. "Following the acquisition of DARA BioSciences and Zuplenz, and further licensing and supply agreements, 2015 has shown significant growth for Midatech, achieving the strategic objectives set out at the time of the IPO and accelerating the company towards sustainable profitability," said Chief Executive Officer Jim Phillips in a statement.
----------
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
29 Jan 2019 16:56

Midatech Pharma To Raise GBP8 Million, Enters Licence Deal (ALLISS)

LONDON (Alliance News) - Midatech Pharma PLC on Tuesday said it entered into conditional agreements to raise GBP8 million by way of a subscription for new ordinary shares at 3.85 pence per on of a

Read more
25 Jan 2019 17:18

LONDON MARKET CLOSE: Stocks Mixed As Miners Rise But Vodafone Sinks

LONDON (Alliance News) - Stocks in London finished the week mixed as commodity miners were unable to keep the FTSE 100 in the green with Vodafone dragging the index lower.The FTSE 100 closed down

Read more
25 Jan 2019 10:40

WINNERS & LOSERS SUMMARY: Earthport Gains As Mastercard Out Bids Visa

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 3.2%. UBS raised the Mexican miner to Buy

Read more
25 Jan 2019 09:51

Midatech Pharma Shares Halve Amid Urgent Scramble To Secure Cash

LONDON (Alliance News) - Shares in Midatech Pharma PLC more than halved Friday as it said it is urgently looking to conclude a deal with a strategic investor with cash funds rapidly running the it

Read more
25 Jan 2019 08:35

Midatech seeking cash after FDA feedback

(Sharecast News) - Oncology and rare disease-focussed company Midatech Pharma announced on Friday that it has received feedback from the US Food and Drug Administration (FDA) on the regulatory study for its lead product, 'MTD201 Q-Octreotide'.

Read more
20 Dec 2018 10:12

Midatech inks evaluation agreement with Asian pharma outfit

(Sharecast News) - Pharmaceutical research and development outfit Midatech has inked an agreement with an unnamed company to evaluate its Q-Sphera drug delivery platform.

Read more
1 Nov 2018 11:37

Midatech Pharma Completes Sale Of US Business To Kanwa Holdings

LONDON (Alliance News) - Immunotherapy-focused pharmaceutical company Midatech Pharma PLC said on Thursday it has completed sale of Midatech Pharma US Inc to Kanwa Holdings LP, owned by Baring for

Read more
8 Oct 2018 15:59

UK Shareholder Meetings Calendar - Next 7 Days

Tuesday 9 Octoberno events scheduledWednesday 10 October Whitbread (sale of Costa

Read more
27 Sep 2018 10:44

Midatech Narrows Loss, Agrees Sale Of US Unit For Up To USD19 million

LONDON (Alliance News) - Midatech Pharma PLC reported a narrowed interim loss as it planned to divest its US unit to become a "pure play biotech company".Total revenue for the six

Read more
31 Aug 2018 10:36

WINNERS & LOSERS SUMMARY: Whitbread Surges On Costa Coffee Sale

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 16%. The hospitality firm said it agreed the

Read more
31 Aug 2018 09:38

Midatech Pharma Shares Rise Following Positive MTD201 Trial Data

LONDON (Alliance News) - Shares in Midatech Pharma PLC jumped on Friday following positive data from its proof of concept exploratory study for its key oncology drug candidate MTD201.Shares

Read more
25 Jul 2018 12:26

Midatech Expects 16% Half-Year Revenue Increase Amid Confident Outlook

LONDON (Alliance News) - Midatech Pharma PLC said Wednesday it expects to meet market expectations for 2018 after increasing half-year revenue year-on-year.For the six months to June 30, it

Read more
25 Jul 2018 10:15

Midatech Pharma 'on track' for first half

(Sharecast News) - Cancer-focused pharmaceutical company Midatech Pharma has remained "on track" to deliver financial results for the first half of the calendar year in line with market expectations, and was still exploring options about how to meet its cash flow needs.

Read more
25 May 2018 12:23

Midatech Pharma Commences First In-Human Study Of Brain Cancer Drug

LONDON (Alliance News) - Midatech Pharma PLC said Friday it started the first in-human study of childhood brain cancer drug MTX110.The study will be a combined phase 1 and phase 2 clinical

Read more
3 May 2018 12:14

MidaTech Pharma "Not Aware Of Any Reason" For Sharp Share Price Drop

LONDON (Alliance News) - Midatech Pharma PLC said Thursday that it is "not aware of any reason" behind the sharp drop in its share price.Midatech shares were down 22% at 35.80 its

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.